Literature DB >> 2341813

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

J E Hixson1, D T Vernier.   

Abstract

We have used restriction isotyping (restriction enzyme isoform genotyping) for rapid typing of common apolipoprotein E isoforms (E2, E3, E4). ApoE restriction isotyping used oligonucleotides to amplify apolipoprotein E gene sequences containing amino acid positions 112 and 158. The amplification products were digested with HhaI and subjected to electrophoresis on polyacrylamide gels. Each of the isoforms was distinguished by a unique combination of HhaI fragment sizes that enabled unambiguous typing of all homozygotic and heterozygotic combinations. HhaI cleaves at GCGC encoding 112arg (E4) and 158arg (E3, E4), but does not cut at GTGC encoding 112cys (E2, E3) and 158cys (E2).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341813

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  707 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

3.  Rapid analysis of amplified double-stranded DNA by capillary electrophoresis with laser-induced fluorescence detection.

Authors:  M S Liu; F T Chen
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

4.  Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.

Authors:  Quan Yuan; Changbiao Chu; Jianping Jia
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

Review 5.  Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis.

Authors:  I Peter; M D Crosier; M Yoshida; S L Booth; L A Cupples; B Dawson-Hughes; D Karasik; D P Kiel; J M Ordovas; T A Trikalinos
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

6.  Age-varying association between statin use and incident Alzheimer's disease.

Authors:  Ge Li; Jane B Shofer; Isaac C Rhew; Walter A Kukull; Elaine R Peskind; Wayne McCormick; James D Bowen; Gerard D Schellenberg; Paul K Crane; John C S Breitner; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

7.  Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.

Authors:  Afef Achouri-Rassas; Sondes Hadj Fredj; Hela Mrabet Khiari; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  Neurochem Res       Date:  2013-12-11       Impact factor: 3.996

8.  BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.

Authors:  Boris Decourt; Amanda Gonzales; Thomas G Beach; Michael Malek-Ahmadi; Aaron Walker; Lucia Sue; Douglas G Walker; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2013-03       Impact factor: 3.498

9.  Arterial pulse wave velocity and cognition with advancing age.

Authors:  Merrill F Elias; Michael A Robbins; Marc M Budge; Walter P Abhayaratna; Gregory A Dore; Penelope K Elias
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

10.  Apolipoprotein E polymorphism and clinical course in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Il-Soo Kim; Byung-Cheol Lee; Kang-Duk Choi; Joo-Ho Chung; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2003-02-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.